STING Protein

STING Protein

Pathway Diagram

Overview

STING (Stimulator of Interferon Genes), also known as TMEM173 or Transmembrane Protein 173, is a cytosolic adaptor protein that functions as a key sensor and transducer of cellular danger signals. Located in the endoplasmic reticulum and Golgi apparatus, STING acts as a central hub in the innate immune response by detecting cytosolic DNA and cyclic dinucleotides. The protein is approximately 43 kDa in size and contains four transmembrane domains that anchor it to intracellular membranes. As a critical component of the cGAS-STING pathway, STING bridges innate immunity with inflammatory responses and has emerged as an important factor in neuroinflammation associated with neurodegeneration.

Function/Biology

STING Protein

Pathway Diagram

Overview

STING (Stimulator of Interferon Genes), also known as TMEM173 or Transmembrane Protein 173, is a cytosolic adaptor protein that functions as a key sensor and transducer of cellular danger signals. Located in the endoplasmic reticulum and Golgi apparatus, STING acts as a central hub in the innate immune response by detecting cytosolic DNA and cyclic dinucleotides. The protein is approximately 43 kDa in size and contains four transmembrane domains that anchor it to intracellular membranes. As a critical component of the cGAS-STING pathway, STING bridges innate immunity with inflammatory responses and has emerged as an important factor in neuroinflammation associated with neurodegeneration.

Function/Biology

STING operates as a downstream effector in the cyclic GMP-AMP synthase (cGAS) pathway. When cGAS detects cytosolic double-stranded DNA (dsDNA)—either from viral infection, cellular damage, or abnormal DNA localization—it catalyzes the synthesis of 2'3'-cyclic GMP-AMP (cGAMP), a cyclic dinucleotide second messenger. cGAMP directly binds to STING's ligand-binding pocket, inducing a conformational change that enables STING to recruit and activate downstream kinases. Specifically, STING recruits Tank-binding kinase 1 (TBK1) and inhibitor of nuclear factor kappa-B kinase (IKK), leading to phosphorylation and activation of interferon regulatory factor 3 (IRF-3) and nuclear factor-kappa B (NF-κB). These transcription factors translocate to the nucleus and drive expression of type I interferons (particularly IFN-β) and pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6).

STING can also be activated by other ligands, including bacterial cyclic dinucleotides like c-di-GMP and c-di-AMP. Additionally, dysregulated calcium signaling and ER stress can modulate STING activity, making it responsive to multiple cellular perturbations. Following activation, STING undergoes palmitoylation and oligomerization, forming signaling complexes that facilitate TBK1 recruitment. Notably, STING can be degraded through selective autophagy (xenophagy), providing negative feedback regulation of inflammatory responses.

Role in Neurodegeneration

STING's involvement in neurodegeneration reflects a dual role: its normal function protects against infections and cellular threats, but chronic or dysregulated activation promotes neuroinflammation. In Alzheimer's disease, emerging evidence suggests that STING activation contributes to microglial activation and neuroinflammation. Accumulating amyloid-beta and tau pathology can trigger release of mitochondrial DNA into the cytosol, potentially activating the cGAS-STING axis in both neurons and immune cells. Similarly, in Parkinson's disease, STING activation has been implicated in dopaminergic neuroinflammation, particularly in response to α-synuclein pathology and mitochondrial dysfunction.

STING also plays roles in ALS-related neuroinflammation, particularly in response to C9orf72 repeat expansions, which can generate aberrant RNA structures and DNA damage triggering STING activation. In Huntington's disease, mutant huntingtin protein-induced mitochondrial stress may activate STING signaling. Chronic STING activation promotes sustained type I interferon signaling, which recruits infiltrating immune cells and perpetuates neuroinflammation that accelerates neuronal death.

Molecular Mechanisms

STING-mediated neurodegeneration operates through multiple interconnected mechanisms. Chronic IFN-β signaling through IFNAR receptors on neurons can induce proapoptotic gene expression and sensitize cells to excitotoxic stress. In microglia, STING-driven NF-κB activation promotes production of pro-inflammatory mediators including TNF-α, IL-1β, and IL-6, which further damage neurons through receptor-mediated toxicity. STING activation also stimulates production of reactive oxygen species (ROS) and reactive nitrogen species (RNS), contributing to oxidative stress within the neuroinflammatory microenvironment.

Additionally, STING participates in autophagy pathways, and dysregulation can impair clearance of protein aggregates—a hallmark of most neurodegenerative diseases. Altered STING signaling also affects mitochondrial function directly, potentially accelerating neuronal death through energy depletion and bioenergetic failure.

Clinical/Research Significance

STING inhibition represents an emerging therapeutic strategy for neurodegenerative diseases complicated by neuroinflammation. Small-molecule STING inhibitors and antagonists have demonstrated neuroprotective effects in preclinical models of multiple neurodegenerative conditions. Understanding STING regulation may enable development of selective modulators that suppress harmful chronic activation while preserving protective innate immune responses.

Relate